The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction

References

• Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology. Eur Heart J 2010;31:2369–429.
   PubMed Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516–21.
   PubMed Web of Science ®Google Scholar
• Uyarel H, Onat A, Yuksel H, Can G, Ordu S, Dursunoğlu D. Incidence, prevalence, and mortality estimates for chronic atrial fibrillation in Turkish adults. Turk Kardiyol Dern Ars 2008;36:214–22.
   PubMedGoogle Scholar
• Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009;30:1038–45.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719–47.
   PubMed Web of Science ®Google Scholar
• Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997;30:406–13.
   PubMed Web of Science ®Google Scholar
• Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial. Card Electrophysiol Rev 2003;7:201–7.
   PubMedGoogle Scholar
• Shinagawa K, Derakhchan K, Nattel S. Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy. Pacing Clin Clectrophysiol 2003;26:752–64.
   PubMed Web of Science ®Google Scholar
• Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007;115:135–43.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525–38.
   PubMed Web of Science ®Google Scholar
• Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van ‘T Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569–619.
   PubMed Web of Science ®Google Scholar
• Folland ED, Parisi AF. Noninvasive evaluation of left ventricular function: the ejection fraction. Compr Ther 1979;5:47–54.
   PubMedGoogle Scholar
• Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277–85.
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–11.
   PubMed Web of Science ®Google Scholar
• Aronson D, Boulos M, Suleiman A, Bidoosi S, Agmon Y, Kapeliovich M, Beyar R, Markiewicz W, Hammerman H, Suleiman M. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol 2007;100:753–7.
   PubMed Web of Science ®Google Scholar
• Elahi MM, Kong YX, Matata BM. Oxidative stress as a mediator of cardiovascular disease. Oxid Med Cell Longev 2009;2:259–69.
   PubMed Web of Science ®Google Scholar
• Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673–8.
   PubMed Web of Science ®Google Scholar
• Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E, Ozguner F, Dogan A, Ibrisim E. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 2008;29:625–31.
   PubMed Web of Science ®Google Scholar
• Rasoli S, Kakouros N, Harling L, Gukop P, Soni M, Athanasiou T, Kourliouros A. Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence? Cardiol Res Pract 2011;2011:164078.
   PubMedGoogle Scholar
• Hicks JJ, Montes-Cortes DH, Cruz-Dominguez MP, Medina-Santillan R, Olivares-Corichi IM. Antioxidants decrease reperfusion induced arrhythmias in myocardial infarction with ST-elevation. Front Biosci 2007;12:2029–37.
   PubMed Web of Science ®Google Scholar
• Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circulation 2001;89:E32–8.
   Web of Science ®Google Scholar
• Ozaydin M, Icli A, Yucel H, Akcay S, Peker O, Erdogan D, Varol E, Dogan A, Okutan H. Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study. Eur Heart J 2013;34:597–604.
   PubMed Web of Science ®Google Scholar
• Kim YH, Lim DS, Lee JH, Shim WJ, Ro YM, Park GH, Becker KG, Cho-Chung YS, Kim MK. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 2003;35:336–49.
   PubMed Web of Science ®Google Scholar
• Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174–80.
   PubMed Web of Science ®Google Scholar
• Neuman RB, Bloom HL, Shukrullah I, Darrow LA, Kleinbaum D, Jones DP, Dudley SC Jr. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 2007;53:1652–7.
   PubMed Web of Science ®Google Scholar
• Rabus M, Demirbag R, Yildiz A, Tezcan O, Yilmaz R, Ocak AR, Alp M, Erel O, Aksoy N, Yakut C. Association of prolidase activity, oxidative parameters, and presence of atrial fibrillation in patients with mitral stenosis. Arch Med Res 2008;39:519–24.
   PubMed Web of Science ®Google Scholar
• Köroğlu S, Tuncer C, Acar G, Akçay A, Sökmen G, Yalçıntaş S, Nacar A, Altun B, Sökmen A. Relation of inflammatory and oxidative markers to the occurrence and recurrence of persistent atrial fibrillation. Turk Kardiyol Dern Ars 2012;40:499–504.
   PubMedGoogle Scholar
• Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886–91.
   PubMed Web of Science ®Google Scholar
• Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000;18:655–73.
   PubMed Web of Science ®Google Scholar
• Goette A, Lendeckel U. Nonchannel drug targets in atrial fibrillation. Pharmacol Ther 2004;102:17–36.
   PubMed Web of Science ®Google Scholar
• Ozaydin M, Peker O, Erdogan D, Akcay S, Yucel H, Icli A, Ceyhan BM, Sutcu R, Uysal BA, Varol E, Dogan A, Okutan H. Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment. Clin Cardiol 2014;37:300–6.
   PubMed Web of Science ®Google Scholar
• Borekci A, Gur M, Turkoglu C, Selek S, Baykan AO, Seker T, Seker T, Harbalıoglu H, Ozaltun B, Makca I, Aksoy N, Gozukara Y, Caylı M. Oxidative stress and spontaneous reperfusion of infarct-related artery in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost 2016;22:171–7.
   PubMed Web of Science ®Google Scholar
• Turan T, Mentese U, Agac MT, Akyuz AR, Kul S, Aykan AC, Bektas H, Korkmaz L, Oztas Mentese S, Dursun I, Celik S. The relation between intensity and complexity of coronary artery lesion and oxidative stress in patients with acute coronary syndrome. Anatol J Cardiol 2015;15:795–800.
   PubMed Web of Science ®Google Scholar
• Ozaydin M. Atrial fibrillation and inflammation. World J Cardiol 2010;2:243–50.
   PubMedGoogle Scholar
• Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008;52:306–13.
   PubMed Web of Science ®Google Scholar
• Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006–10.
   PubMed Web of Science ®Google Scholar
• Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180–4.
   PubMed Web of Science ®Google Scholar
• Gedikli O, Dogan A, Altuntas I, Altinbas A, Ozaydin M, Akturk O, Acar G. Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 2007;120:193–7.
   PubMed Web of Science ®Google Scholar
• Malouf JF, Kanagala R, Al Atawi FO, Rosales AG, Davison DE, Murali NS, Tsang TS, Chandrasekaran K, Ammash NM, Friedman PA, Somers VK. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol 2005;46:1284–7.
   PubMed Web of Science ®Google Scholar
• Deftereos S, Giannopoulos G, Angelidis C, Alexopoulos N, Filippatos G, Papoutsidakis N, Sianos G, Goudevenos J, Alexopoulos D, Pyrgakis V, Cleman MW, Manolis AS, Tousoulis D, Lekakis J. Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study. Circulation 2015;132:1395–403.
   PubMed Web of Science ®Google Scholar
• Hwang HJ, Ha JW, Joung B, Choi EH, Kim J, Ahn MS, Lee MH, Jang Y, Chung N, Kim SS. Relation of inflammation and left atrial remodeling in atrial fibrillation occurring in early phase of acute myocardial infarction. Int J Cardiol 2011;146:28–31.
   PubMed Web of Science ®Google Scholar
• Gedikli O, Orem C, Baykan M, Karahan C, Kucukosmanoglu M, Sahin S, Korkmaz L, Yilmaz H, Celik S. Association between serum C-reactive protein elevation and atrial fibrillation after first anterior myocardial infarction. Clin Cardiol 2008;31:482–7.
   PubMed Web of Science ®Google Scholar
• Ozaydin M, Turker Y, Erdogan D, Karabacak M, Dogan A, Varol E, Gonul E, Altinbas A. The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome. Int J Cardiol 2010;141:147–50.
   PubMed Web of Science ®Google Scholar
• Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, Santoro L, Tognoni G. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 2001;86:527–32.
   PubMed Web of Science ®Google Scholar
• Gal P, Parlak E, Schellings DA, Beukema R, ten Berg J, Adiyaman A, van ‘T Hof AW, Elvan A. Association of serial high sensitivity troponin T with onset of atrial fibrillation in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care 2016;5:33–42.
   PubMed Web of Science ®Google Scholar